GN Store Nord A/S (GN.CO)
DKK 94.26
(-0.06%)
DKK 94.26
(-0.06%)
| Year | Eps | Eps Growth |
|---|---|---|
| 2023 | 1.64 DKK | -59.0% |
| 2022 | 4.00 DKK | -70.65% |
| 2021 | 13.63 DKK | 40.23% |
| 2020 | 9.72 DKK | -12.59% |
| 2019 | 11.12 DKK | 20.22% |
| 2018 | 9.25 DKK | 8.7% |
| 2017 | 8.51 DKK | 21.92% |
| 2016 | 6.98 DKK | 35.27% |
| 2015 | 5.16 DKK | 5.52% |
| 2014 | 4.89 DKK | 11.14% |
| 2013 | 4.40 DKK | 144.44% |
| 2012 | 1.80 DKK | -58.24% |
| 2011 | 4.31 DKK | -52.9% |
| 2010 | 9.15 DKK | 2791.18% |
| 2009 | -0.34 DKK | -25.93% |
| 2008 | -0.27 DKK | 41.3% |
| 2007 | -0.46 DKK | -70.37% |
| 2006 | -0.27 DKK | -106.62% |
| 2005 | 4.08 DKK | 253.96% |
| 2004 | -2.65 DKK | -96.3% |
| 2003 | -1.35 DKK | -105.22% |
| 2002 | 25.86 DKK | 0.0% |
| Year | Eps | Eps Growth |
|---|---|---|
| 2024 Q2 | 0.66 DKK | -62.07% |
| 2024 Q1 | 1.74 DKK | 544.44% |
| 2023 Q2 | 0.23 DKK | 167.65% |
| 2023 Q4 | 0.27 DKK | -81.63% |
| 2023 Q3 | 1.47 DKK | 539.13% |
| 2023 FY | - DKK | -59.0% |
| 2023 Q1 | -0.34 DKK | -116.5% |
| 2022 Q4 | 2.06 DKK | 33.77% |
| 2022 Q2 | 1.89 DKK | 235.97% |
| 2022 FY | - DKK | -70.65% |
| 2022 Q3 | 1.54 DKK | -18.52% |
| 2022 Q1 | -1.39 DKK | -141.74% |
| 2021 FY | - DKK | 40.23% |
| 2021 Q1 | 3.66 DKK | -10.51% |
| 2021 Q3 | 3.37 DKK | 2.43% |
| 2021 Q4 | 3.33 DKK | -1.19% |
| 2021 Q2 | 3.29 DKK | -10.11% |
| 2020 Q1 | 0.78 DKK | -81.69% |
| 2020 Q3 | 4.78 DKK | 4680.0% |
| 2020 Q4 | 4.09 DKK | -14.44% |
| 2020 Q2 | 0.10 DKK | -87.18% |
| 2020 FY | - DKK | -12.59% |
| 2019 Q4 | 4.26 DKK | 63.85% |
| 2019 Q3 | 2.60 DKK | 13.54% |
| 2019 FY | - DKK | 20.22% |
| 2019 Q2 | 2.29 DKK | 16.84% |
| 2019 Q1 | 1.96 DKK | -40.96% |
| 2018 Q2 | 2.11 DKK | 34.39% |
| 2018 Q4 | 3.32 DKK | 47.56% |
| 2018 FY | - DKK | 8.7% |
| 2018 Q1 | 1.57 DKK | -40.53% |
| 2018 Q3 | 2.25 DKK | 6.64% |
| 2017 FY | - DKK | 21.92% |
| 2017 Q2 | 1.90 DKK | 34.75% |
| 2017 Q4 | 2.64 DKK | 28.78% |
| 2017 Q3 | 2.05 DKK | 7.89% |
| 2017 Q1 | 1.41 DKK | -44.27% |
| 2016 Q4 | 2.53 DKK | 72.11% |
| 2016 FY | - DKK | 35.27% |
| 2016 Q3 | 1.47 DKK | -6.37% |
| 2016 Q1 | 1.38 DKK | -38.12% |
| 2016 Q2 | 1.57 DKK | 13.77% |
| 2015 FY | - DKK | 5.52% |
| 2015 Q4 | 2.23 DKK | 75.59% |
| 2015 Q3 | 1.27 DKK | 149.02% |
| 2015 Q2 | 0.51 DKK | -56.41% |
| 2015 Q1 | 1.17 DKK | -39.69% |
| 2014 Q1 | 1.04 DKK | -27.78% |
| 2014 FY | - DKK | 11.14% |
| 2014 Q2 | 1.17 DKK | 12.5% |
| 2014 Q3 | 0.73 DKK | -37.61% |
| 2014 Q4 | 1.94 DKK | 165.75% |
| 2013 Q1 | 0.77 DKK | 42.59% |
| 2013 FY | - DKK | 144.44% |
| 2013 Q4 | 1.44 DKK | 25.22% |
| 2013 Q3 | 1.15 DKK | 10.58% |
| 2013 Q2 | 1.04 DKK | 35.06% |
| 2012 Q3 | 0.37 DKK | 0.0% |
| 2012 Q4 | 0.54 DKK | 45.95% |
| 2012 FY | - DKK | -58.24% |
| 2012 Q1 | 0.52 DKK | -81.29% |
| 2012 Q2 | 0.37 DKK | -28.85% |
| 2011 Q3 | 0.58 DKK | -7.94% |
| 2011 Q2 | 0.63 DKK | 133.33% |
| 2011 Q1 | 0.27 DKK | -55.0% |
| 2011 FY | - DKK | -52.9% |
| 2011 Q4 | 2.78 DKK | 379.31% |
| 2010 Q1 | 0.28 DKK | 171.79% |
| 2010 FY | - DKK | 2791.18% |
| 2010 Q4 | 0.60 DKK | -92.42% |
| 2010 Q3 | 7.92 DKK | 2040.54% |
| 2010 Q2 | 0.37 DKK | 32.14% |
| 2009 Q3 | 0.54 DKK | 5500.0% |
| 2009 Q2 | -0.01 DKK | 97.92% |
| 2009 FY | - DKK | -25.93% |
| 2009 Q1 | -0.48 DKK | 0.0% |
| 2009 Q4 | -0.39 DKK | -172.22% |
| 2008 FY | - DKK | 41.3% |
| 2007 FY | - DKK | -70.37% |
| 2006 FY | - DKK | -106.62% |
| 2005 FY | - DKK | 253.96% |
| 2004 FY | - DKK | -96.3% |
| 2003 FY | - DKK | -105.22% |
| 2002 FY | - DKK | 0.0% |
| Name | Eps | Eps Difference |
|---|---|---|
| Ambu A/S | 0.88 DKK | -86.364% |
| ChemoMetec A/S | 7.83 DKK | 79.055% |
| Demant A/S | 8.04 DKK | 79.602% |
| Scandinavian Medical Solutions A/S | 0.45 DKK | -264.444% |
| ViroGates A/S | -3.49 DKK | 146.991% |